ANI Pharmaceuticals ANIP Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's change in AR?
- ANI Pharmaceuticals (ANIP) reported change in AR of -$25.53M in Q1 2026.
- How has ANI Pharmaceuticals's change in AR changed year-over-year?
- ANI Pharmaceuticals's change in AR decreased by 1332.5% year-over-year, from -$1.78M to -$25.53M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.